These results strongly indicate that CA improves cardiac inflammation and myocardial hypertrophy in RH by regulating the expression of MMP9/COX2/TNF α/IL-17 in the TNF and IL-17 signaling pathways. The gene discussed is IL17A; the disease is cardiac hypertrophy.